vTv Therapeutics Inc.vTv Therapeutics Inc.vTv Therapeutics Inc.

vTv Therapeutics Inc.

No trades
See on Supercharts

VTVT fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. It offers Azeliragon, TTP399, TTP273, HPP593, HPP737, and the Nrf2/Bach1 program. The company was founded on April 2, 2015 and is headquartered in High Point, NC.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
VTVT has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company